Figure 2From: Efficacy of a slow-release imidacloprid (10%)/flumethrin (4.5%) collar for the prevention of canine leishmaniosis A control dog showing clinical signs of leishmaniosis (i.e. dry exfoliative dermatitis) at the last follow-up (D300). Back to article page